Cue Biopharma, Inc. Revenue 2018–2025
Cue Biopharma, Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cue Biopharma, Inc. revenue for the quarter ending March 31, 2026 was 5.7 M, a 1250.59% increase year-over-year.
- Cue Biopharma, Inc. revenue for the twelve months ending March 31, 2026 was 11.2 M, a 14.26% increase year-over-year.
- Cue Biopharma, Inc. annual revenue for 2025 was 27.5 M, a 195.75% increase from 2024.
- Cue Biopharma, Inc. annual revenue for 2024 was 9.3 M, a 69.16% increase from 2023.
- Cue Biopharma, Inc. annual revenue for 2023 was 5.5 M, a 340.96% increase from 2022.
- Cue Biopharma, Inc. annual revenue for 2022 was 1.2 M.
Cue Biopharma, Inc. (CUE) — Frequently Asked Questions
Cue Biopharma, Inc. (CUE) is a publicly traded US company. It has a market capitalization of $2.64B. In fiscal 2025 it reported revenue of $27M and net income of -$27M. Explore CUE's stock price, financial statements, earnings history, margins and key ratios below.
What is Cue Biopharma, Inc.'s market cap?
Cue Biopharma, Inc. (CUE) has a market capitalization of $2.64B.
What is the CUE stock price?
CUE trades at $27.82 (-0.14% on the day).
How much revenue does Cue Biopharma, Inc. make?
Cue Biopharma, Inc. reported revenue of $27M in fiscal 2025.
Is CUE profitable?
In fiscal 2025, Cue Biopharma, Inc. reported net income of -$27M.